GSK Pharma Appoints Ronojit Biswas Director CFO

GlaxoSmithKline Pharmaceuticals conducted a postal ballot seeking shareholder approval for two resolutions regarding Ronojit Biswas.
Shareholders approved Biswas' appointment as Director with 99.69% votes in favor and as Whole-time Director & CFO with 99.76% votes in favor.
The e-voting process was conducted from March 9 to April 8, 2026, with 84.04% of total outstanding shares participating in the vote.
P.N. Parikh served as scrutinizer and confirmed the voting results, which have been submitted to BSE and NSE for record.